Omada Health's Sean Duffy plans 14,960-share sale
Sean Duffy files a Rule 144 notice to sell 14,960 OMDA shares from recently vested RSUs, alongside a history of 10b5-1 plan sales in the prior three months.
Rhea-AI Filing Summary
Omada Health, Inc. (OMDA) received a notice under Rule 144 that Sean Duffy intends to sell up to 14,960 shares of common stock through Morgan Stanley Smith Barney LLC, with an indicated aggregate sale price of $321,640.00 on or about September 10, 2026.
The shares come from restricted stock units that vested during the period of September 1, 2026 through September 5, 2026. The filing also lists multiple prior 10b5-1 plan sales of Omada common stock by Sean Duffy over the preceding three months, each with its own share count and dollar amount.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold under Rule 144: 14,960 shares
Aggregate sale price for planned Rule 144 sale: $321,640.00
Planned sale date reference: September 10, 2026
+4 more
7 metrics
Planned shares to be sold under Rule 144
14,960 shares
Common stock listed for sale by Sean Duffy through Morgan Stanley Smith Barney LLC
Aggregate sale price for planned Rule 144 sale
$321,640.00
Indicated aggregate market value for 14,960 common shares
Planned sale date reference
September 10, 2026
Date associated with the planned sale of 14,960 shares and Date of Notice
10b5-1 sale on September 1, 2026
12,944 shares for $305,682.92
One of the reported 10b5-1 sales of Omada common stock
10b5-1 sale on August 10, 2026
12,942 shares for $321,058.67
Another 10b5-1 sale by Sean Duffy reported in the past three months
10b5-1 sale on June 16, 2026
14,960 shares for $259,711.58
Reported prior 10b5-1 sale of Omada common stock
Issuer phone number
888-987-8337
Contact phone listed for Omada Health, Inc.
Key Terms
Rule 144, restricted stock units, 10b5-1
3 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
restricted stock units financial
"The securities to be sold were acquired upon the vesting of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
10b5-1 regulatory
"10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
FAQ
What does the Rule 144 filing disclose about planned sales of OMDA stock?
The notice states that Sean Duffy intends to sell up to 14,960 shares of Omada Health common stock under Rule 144, with an indicated aggregate sale price of $321,640.00, through Morgan Stanley Smith Barney LLC around September 10, 2026.
Which broker is involved in the planned OMDA stock sale under Rule 144?
The Rule 144 notice lists Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, as the broker handling the planned sale of 14,960 common shares of Omada Health, Inc.
What 10b5-1 plan sales of OMDA stock are reported for the past three months?
The filing lists multiple 10b5-1 plan sales by Sean Duffy, including sales such as 12,944 shares for $305,682.92 on September 1, 2026 and 12,942 shares for $293,435.69 on July 1, 2026, among other dated transactions.
Who is the person named in the OMDA Rule 144 notice and what security is involved?
The notice is filed for Sean Duffy, relating to sales of common stock of Omada Health, Inc. The securities are reported as being sold under Rule 144, with both planned and past 10b5-1 sales detailed.
When was the Rule 144 notice for OMDA stock dated and signed?
The Rule 144 notice shows a Date of Notice of September 10, 2026 and includes a signature line executed as “/s/ Sean P. Duffy”, indicating submission of the notice for the planned sale.
AI-generated analysis. How Rhea-AI works. Not financial advice.
